Leaflet SAFLUTAN 15mcg / ml ophthalmic drops single-dose solution

Product code:
W62677001
Quantity:
30
Indicated for:
glaucoma; ocular hypertension
Route of administration:
ophthalmic
Substance:
tafluprost (glaucoma agent)
ATC
S01EE05 — Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues
Tafluprost is a prostaglandin analog used for the treatment of open-angle glaucoma and ocular hypertension. It lowers intraocular pressure by increasing the outflow of aqueous humor from the eye.

The medication is administered as eye drops, usually once daily, as directed by a doctor. It is important for patients to follow the usage instructions to achieve maximum efficacy.

Patients should be aware of potential side effects, such as eye irritation, redness, or changes in iris pigmentation. It is important to inform the doctor of any unusual symptoms.

Common side effects include eye irritation, a burning or itching sensation, and gradual changes in iris color. In rare cases, allergic reactions or ocular inflammation may occur. Patients should be informed of these risks before starting treatment.

General data about SAFLUTAN 15mcg / ml

Substance:
tafluprost
Date of latest medicines list:
01-08-2025
Product code:
W62677001
Concentration:
15mcg / ml
Pharmaceutical form:
ophthalmic drops single-dose solution
Packing volume:
0,3ml
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
NEXTPHARMA OY - FINLANDA
Holder:
SANTEN OY - FINLANDA
Number:
6131/2014/01
Shelf life:
3 years;after the first opening a pungii-28 days

Pharmaceutical forms available for tafluprost

Combinations with other substances